Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ASP Data Lag On New Generic Drugs Encourages Generic Utilization – CMS

Executive Summary

CMS says the two-quarter lag in average sales price data for new generic drugs used for reimbursement under Medicare Part B encourages the transition from brand to generic products.

You may also be interested in...



GPhA Gains Medicaid/Medicare Expertise: Coster Joins As VP For Government Affairs

The Generic Pharmaceutical Association's incoming head of government affairs brings a wealth of experience on federal and state reimbursement issues.

GPhA Gains Medicaid/Medicare Expertise: Coster Joins As VP For Government Affairs

The Generic Pharmaceutical Association's incoming head of government affairs brings a wealth of experience on federal and state reimbursement issues.

GPhA Gains Medicaid/Medicare Expertise As Coster Joins As VP For Government Affairs

Long-time pharmacy trade association exec John Coster is tapped to head growing department.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053024

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel